ADVERTISEMENT

Saillant Therapeutics

05-Smarthealt

Saillant Therapeutics Reports Proof of Concept of its Treatment in Heart Failure Showing Functional Reversal and Myocardial Rejuvenation

Using a heart failure animal model found out that the new treatment restored heart function in failing hearts after four weeks of treatment. Saillant Therapeutics, an innovative preclinical stage biotechnology company developing promising small molecule-based therapies, today announced that it has obtained Proof of Concept for its lead compound (ST02) indicated for the treatment of…

Latest News